Top Markets
#1 Purr Purr +59.29%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +32.91%
#4 Kinetiq Kinetiq +30.53%
#5 ApeX ApeX +25.45%
#6 Non-Playable Coin Non-Playable Coin +21.19%
#7 OriginTrail OriginTrail +19.37%
#8 Morpho Morpho +18.34%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.17%
#10 Fake World Assets Fake World Assets +18.14%
Coin of the day
Purr Purr
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Classificação em ações #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Preço da ação
$2.72
Última sincronização: 2023-10-19
Valor de mercado
$111.47M
Variação (1 dia)
-0.73%
Variação (1 ano)
0.00%
País
US
Negociar Talaris Therapeutics, Inc. (TALS)

Categoria

Healthcare
Histórico de preços das ações de Talaris Therapeutics, Inc. (TALS)
Preço de fecho mais alto: $2.72 em 2023-10-01

Preço de fecho mais baixo: $13.89 em 2021-05-01
Histórico de preços das ações da Talaris Therapeutics, Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 124.21%
2022 -91.51%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH